These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 23253701

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.
    Yamaguchi T.
    Stroke; 2000 Apr; 31(4):817-21. PubMed ID: 10753981
    [Abstract] [Full Text] [Related]

  • 23. Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population.
    Currie CJ, McEwan P, Emmas C, Morgan CL, Peters JR.
    Curr Med Res Opin; 2005 Dec; 21(12):1905-13. PubMed ID: 16368039
    [Abstract] [Full Text] [Related]

  • 24. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ, Flegel KM, Orejuela ME, Kelley HE, Speckman JL, Migliaccio-Walle K.
    CMAJ; 1999 Sep 07; 161(5):493-7. PubMed ID: 10497604
    [Abstract] [Full Text] [Related]

  • 25. [The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese].
    Sun YH, Hu DY.
    Zhonghua Nei Ke Za Zhi; 2004 Apr 07; 43(4):258-60. PubMed ID: 15130407
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin.
    Currie CJ, Jones M, Goodfellow J, McEwan P, Morgan CL, Emmas C, Peters JR.
    Heart; 2006 Feb 07; 92(2):196-200. PubMed ID: 15883133
    [Abstract] [Full Text] [Related]

  • 27. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V, Palareti G, Cucchini U, Molinatti M, Del Bono R, Baudo F, Ghirarduzzi A, Pegoraro C, Iliceto S, participating centers of Italian Federation of Anticoagulation Clinics (FCSA).
    Clin Appl Thromb Hemost; 2007 Jul 07; 13(3):241-8. PubMed ID: 17636186
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation.
    Cheung CM, Tsoi TH, Huang CY.
    Cerebrovasc Dis; 2005 Jul 07; 20(2):114-9. PubMed ID: 16006759
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M, Gross B.
    Int J Cardiol; 2004 Jul 07; 96(1):89-95. PubMed ID: 15203266
    [Abstract] [Full Text] [Related]

  • 32. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
    Ezekowitz MD, Reilly PA, Nehmiz G, Simmers TA, Nagarakanti R, Parcham-Azad K, Pedersen KE, Lionetti DA, Stangier J, Wallentin L.
    Am J Cardiol; 2007 Nov 01; 100(9):1419-26. PubMed ID: 17950801
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.
    Ann Pharmacother; 2011 Jul 01; 45(7-8):881-7. PubMed ID: 21750309
    [Abstract] [Full Text] [Related]

  • 36. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R, Lazzerini G, Cocci F, De Caterina R.
    Am Heart J; 2004 Jul 01; 148(1):e6. PubMed ID: 15215815
    [Abstract] [Full Text] [Related]

  • 37. Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials.
    Albers GW, SPORTIF Investigators.
    Am J Manag Care; 2004 Dec 01; 10(14 Suppl):S462-9; discussion S469-73. PubMed ID: 15696910
    [Abstract] [Full Text] [Related]

  • 38. Atrial fibrillation, thromboembolism and antithrombotic therapy.
    Li-Saw-Hee FL, Lip GY.
    Int J Clin Pract; 1999 Mar 01; 53(2):110-7. PubMed ID: 10344046
    [Abstract] [Full Text] [Related]

  • 39. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation.
    Kang F, Ma Y, Cai A, Cheng X, Liu P, Kuang J, Mai Z, Mai W.
    Am J Cardiol; 2021 Mar 01; 142():74-82. PubMed ID: 33307015
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.